Mid-term outcomes and hemodynamic performances of Abbott Epic mitral bioprosthesis: a single-center study
The clinical outcomes of mitral valve replacement with the Epic bioprosthesis are satisfactory, with stable hemodynamics and extremely low incidence of structural valve deterioration and reintervention over 5 years.
Authors
- Akihiro Yoshitake (ORCID: https://orcid.org/0000-0002-5122-3875)
- Yu Miyama (ORCID: https://orcid.org/0000-0001-5901-6961)
- Yuta Kanazawa (ORCID: https://orcid.org/0000-0001-7068-969X)
- Osamu Kinoshita (ORCID: https://orcid.org/0000-0002-0972-3577)
- Toshihisa Asakura (ORCID: https://orcid.org/0000-0002-3420-7881)
- Taiyo Kuroda (ORCID: https://orcid.org/0000-0001-9501-0639)
- Takayuki Gyoten (ORCID: https://orcid.org/0000-0002-7960-6704)
- Takayuki Akatsu
- Yu Kumagai (ORCID: https://orcid.org/0009-0008-4723-0897)
- Yuko Gatate
Institutions
- Saitama International Medical Center (JP)
- Saitama Medical University (JP)
Publication Details
- Journal
- General Thoracic and Cardiovascular Surgery
- Published
- 2025-10-28
- DOI
- https://doi.org/10.1007/s11748-025-02212-4
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Saitama Medical University